Adial Pharmaceuticals Inc (ADIL)
ADIL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.29
-6.00% on the day
Market cap
$8.6M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ADIL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001513525 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | S-3 | 2026-08-28 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-05 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-02 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2026-10-05 |
Source: SEC EDGAR submissions feed, 562 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MBRX | Moleculin Biotech Inc. | $0.4352 | +5.15% | $8.9M |
| IMRN | Immuron Limited | $1.04 | 0.00% | $8.4M |
| CMMB | Chemomab Therapeutics Ltd. American Depositary Share | $1.24 | -10.79% | $9.0M |
| BOLT | Bolt Biotherapeutics Inc. | $4.29 | +1.06% | $8.3M |
| MTVA | MetaVia Inc. | $1.43 | -1.38% | $9.4M |
| VTGN | Vistagen Therapeutics Inc. | $0.2148 | -5.21% | $9.5M |
| CNSP | CNS Pharmaceuticals Inc. | $5.35 | +3.08% | $7.8M |
| TCRT | Alaunos Therapeutics Inc. | $3.03 | +188.57% | $7.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier